Drugs under experimental and clinical research - JoVE Visualize

Showing results (871-880 of 1,361) with videos related to

Pageof 137

Sort By:

Drugs Under Experimental and Clinical Research|January 1, 1988

In vitro influence of charcoal on ciprofloxacin activityD Torre, C Sampietro, C Quadrelli, et al.

Drugs Under Experimental and Clinical Research|January 1, 1988

The kinetics of SHV-2 plasmid-mediated beta-lactamase compared to those of the parent enzyme from which it is derivedR Labia, A Morand, K Tiwari, et al.

Drugs Under Experimental and Clinical Research|January 1, 1988

A long-term study on the use of evening primrose oil (Efamol) in atopic childrenP L Biagi, A Bordoni, M Masi, et al.

Drugs Under Experimental and Clinical Research|July 27, 2004

Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysisS Szabo, D Etzel, R Ehlers, et al.

Drugs Under Experimental and Clinical Research|July 27, 2004

Effects of chronic administration of D-003, a mixture of sugar cane wax high molecular acids, in beagle dogsR Gámez, R Más, M Noa, et al.

Drugs Under Experimental and Clinical Research|June 1, 2005

Nifedipine inhibits tumor necrosis factor-alpha-induced upregulation of monocyte chemoattractant protein-1 mRNA levels by suppressing CD40 expression in endothelial cellsS Yamagishi, M Takeuchi

Drugs Under Experimental and Clinical Research|July 22, 2005

Quercus suber cork extract displays a tensor and smoothing effect on human skin: an in vivo studyC Coquet, E Bauza, G Oberto, et al.

Drugs Under Experimental and Clinical Research|July 22, 2005

Molecular mechanisms for vascular injury in the metabolic syndromeS Yamagishi, K Nakamura, Y Jinnouchi, et al.

Drugs Under Experimental and Clinical Research|January 1, 1992

Inhibition of EGF-induced cytoskeletal change in A431 cells by inhibitors of phosphatidylinositol turnoverN Johtoh, K Umezawa

Drugs Under Experimental and Clinical Research|January 1, 1992

Modifications of "A cells" in the development of experimentally induced pancreatic ductal adenocarcinoma: an ultrastructural and immunohistochemical studyM M Abad, J I Paz-Bouza, M Arévalo, et al.

Pageof 137

Showing results (871-880 of 1,361) with videos related to

Sort By:

Pageof 137

Drugs Under Experimental and Clinical Research|January 1, 1988

In vitro influence of charcoal on ciprofloxacin activityD Torre, C Sampietro, C Quadrelli, et al.

Drugs Under Experimental and Clinical Research|January 1, 1988

The kinetics of SHV-2 plasmid-mediated beta-lactamase compared to those of the parent enzyme from which it is derivedR Labia, A Morand, K Tiwari, et al.

Drugs Under Experimental and Clinical Research|January 1, 1988

A long-term study on the use of evening primrose oil (Efamol) in atopic childrenP L Biagi, A Bordoni, M Masi, et al.

Drugs Under Experimental and Clinical Research|July 27, 2004

Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysisS Szabo, D Etzel, R Ehlers, et al.

Drugs Under Experimental and Clinical Research|July 27, 2004

Effects of chronic administration of D-003, a mixture of sugar cane wax high molecular acids, in beagle dogsR Gámez, R Más, M Noa, et al.

Drugs Under Experimental and Clinical Research|June 1, 2005

Nifedipine inhibits tumor necrosis factor-alpha-induced upregulation of monocyte chemoattractant protein-1 mRNA levels by suppressing CD40 expression in endothelial cellsS Yamagishi, M Takeuchi

Drugs Under Experimental and Clinical Research|July 22, 2005

Quercus suber cork extract displays a tensor and smoothing effect on human skin: an in vivo studyC Coquet, E Bauza, G Oberto, et al.

Drugs Under Experimental and Clinical Research|July 22, 2005

Molecular mechanisms for vascular injury in the metabolic syndromeS Yamagishi, K Nakamura, Y Jinnouchi, et al.

Drugs Under Experimental and Clinical Research|January 1, 1992

Inhibition of EGF-induced cytoskeletal change in A431 cells by inhibitors of phosphatidylinositol turnoverN Johtoh, K Umezawa

Drugs Under Experimental and Clinical Research|January 1, 1992

Modifications of "A cells" in the development of experimentally induced pancreatic ductal adenocarcinoma: an ultrastructural and immunohistochemical studyM M Abad, J I Paz-Bouza, M Arévalo, et al.

Pageof 137